Global emergence of Escherichia coli with PBP3 insertions
Journal of Antimicrobial Chemotherapy · 03.01.2025 · 80 (1) · 178-181
DOI: 10.1093/jac/dkae393 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Antimicrobial Chemotherapy, online erschienen am 30.10.2024. Verfasst von Haiyan Long und 3 weiteren Autor:innen. Beteiligte Einrichtung: Center of Infectious Diseases, West China Hospital, Sichuan University, Guoxuexiang 37, Chengdu 610041, China. Hauptthemen laut MEDLINE: Escherichia coli, Penicillin-Binding Proteins, Escherichia coli Infections. Die Arbeit wurde bisher 41-mal zitiert (Crossref) und nennt 24 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China, Natural Science Foundation of Sichuan Province.
Abstract (Originalsprache)
Objectives
Escherichia coli producing metallo-β-lactamases with penicillin-binding protein 3 (PBP3) insertions have reduced susceptibility to aztreonam–avibactam and cefiderocol. Here, we analysed high-quality E. coli genomes for PBP3 insertions.
Methods
E. coli genomes (n = 167 518) were retrieved from EnteroBase with CheckM2 for quality control, fastANI for species confirmation, multi-locus sequencing typing for sequence type (ST) determination and AMRFinderPlus for resistance gene identification. For PBP3 insertion analysis, we used Prokka for predicting coding sequences, BLAST+ for comparing resulted protein sequences and SnpEff for annotating variants.
Results
Among the included 159 341 genomes, PBP3 insertions with 11 variants were found in 2.01% (n = 3198). The predominant variant is a duplication of 334–337 amino acids (aa) (94.75%, n = 3030), comprising YRIN (65.92%, n = 2108) and its single-aa-variant YRIK (28.83%, n = 922), followed by a similar PYRI duplication of 333–336 (4.16%, n = 133). The less common ones are a TIPY duplication of 331–334 (n = 24) and its single-aa-variant TVPY’s duplication: TVVPY (n = 1), TVPYTVPY (n = 1) and TVPYPVPY (n = 1). Rare duplications include VGDR of 106–109 (n = 3), ANALNIPL of 114–121 (n = 3), AL of 567–568 (n = 1) and TG of 584–585 (n = 1). Insertion variants were detected across 62 countries on six continents, primarily in human samples, and associated with 85 STs, concentrated in high-risk clones ST410 (29.18%, n = 1923), ST167 (23.40%, n = 1740) and ST405 (10.56%, n = 1334), with 83.32% (n = 2218) encoding metallo-β-lactamase NDM.
Conclusions
Global spread of E. coli harbouring PBP3 insertion, often with NDM β-lactamase, high-risk ST410, ST167 and ST405 clones and various hosts, underscores the escalating antimicrobial resistance crisis and the urgency for a ‘One Health’ strategy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Center of Infectious Diseases, West China Hospital, Sichuan University, Guoxuexiang 37, Chengdu 610041, China.
- Center for Pathogen Research, West China Hospital, Sichuan University, Chengdu, China.
ORCID-Profile: Zhiyong Zong
Förderung
- National Natural Science Foundation of China
- National Key Research and Development Program of China
- Natural Science Foundation of Sichuan Province
- West China Hospital of Sichuan University
Zitieren
APA
Long, H., Zhao, F., Feng, Y., & Zong, Z. (2025). Global emergence of Escherichia coli with PBP3 insertions. Journal of Antimicrobial Chemotherapy, 80(1), 178-181. https://doi.org/10.1093/jac/dkae393
Vancouver
Long H, Zhao F, Feng Y, Zong Z. Global emergence of Escherichia coli with PBP3 insertions. Journal of Antimicrobial Chemotherapy. 2025;80(1):178-181. doi:10.1093/jac/dkae393
BibTeX
@article{Long2025,
author = {Long, Haiyan and Zhao, Feifei and Feng, Yu and Zong, Zhiyong},
title = {Global emergence of Escherichia coli with PBP3 insertions},
journal = {Journal of Antimicrobial Chemotherapy},
year = {2025},
volume = {80},
number = {1},
pages = {178--181},
doi = {10.1093/jac/dkae393}
}
EUVIMED